Enfermedades Infecciosas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Fernandez-Ibanez R, Moreno S, Fernandez M.

    A Review of Doxycycline Post-Exposure Prophylaxis and Its Implications for Antimicrobial Resistance and the Human Microbiome

    Infectious diseases and therapy . 15(1): 57-84.

    [doi:10.1007/s40121-025-01270-8]

  • Casado JL, Vizcarra P, Hernández-Walias FJ, Manuel Del Rey J, Santiuste C, Molano C, Menacho M, Vallejo A.

    Urinary exosome-derived microRNAs as biomarkers of tenofovir disoproxil fumarate (TDF)-induced renal toxicity in people with HIV-1

    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS . 67(1): 107654-107654.

    [doi:10.1016/j.ijantimicag.2025.107654]

  • De La Villa S, Fernández-Hidalgo N, Escrihuela-Vidal F, Escudero-Sánchez R, Cabezón I, Boix-Palop L, Díaz-Pollán B, Goikoetxea AJ, García-País MJ, Ramos-Merino L, Pérez-Rodríguez MT, Crespo Á, Del Río L, Bellón-Cano JM, Muñoz P.

    Analysis of Clinical Subphenotypes in Methicillin-Resistant Staphylococcus aureus Bacteremia: A Post Hoc Analysis of the MRSA-GEIRAS-SEIMC Study

    Open forum infectious diseases . 12(12): .

    [doi:10.1093/ofid/ofaf704]

  • Diab Casares L, Espinosa Pereiro J, Tórtola Fernández MT, Casas García X, Millet JP, Pomar Solchaga V, Navas Elorza E, Troya García J, Díaz de Santiago A, Luque Márquez R, Medina Gallardo JF, González Galán V, Montero Alonso M, Gil Brusola A, Rabuñal Rey R, Anibarro García L, Sanz Herrero F, Guna Serrano R, Garrigó Fullola M, Tato Díez M, Talavan Zanón T, Portero MF, Alonso García P, Saez López AM, Aznar ML, Martínez Campreciós J, Saborit N, Sánchez Montalvá A.

    Multicentre controlled open randomised clinical trial to assess efficacy and safety of an anti-tuberculosis drug combination based on optimised-dose rifampicin, optimised-dose moxifloxacin and optimised-dose linezolid for TB: the RML-TB trial protocol

    BMJ Open Respiratory Research . 12(1): .

    [doi:10.1136/bmjresp-2024-002475]

  • De La Torre Tarazona E, Calderón-Vicente S, Fons-Contreras M, Rava M, Ruiz-Sancho AL, Rivero A, Macías J, Olalla J, Alcaraz Vidal B, Rodríguez Díaz D, Alcamí J, Muriel A, Serrano-Villar S, Moreno S.

    Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIV.

    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES . 163: 108306-108306.

    [doi:10.1016/j.ijid.2025.108306]

  • Sánchez-Menéndez C, Rodríguez-Pérez J, Fuertes D, Leguizamon V, González-Sanmartín M, Mateos E, Cervero M, San José E, Sanz G, Álvaro E, Ballestero-Pérez A, Martí-Gallostra M, Rueda JA, Hurtado-Caballero E, Pastor C, Balaguer F, Spinelli A, Martínez-Laso J, Torres M, Perea J, Coiras M.

    Differences in the peripheral blood immune landscape between early-onset and late-onset colorectal cancer

    Frontiers in immunology . 16: 1692382-1692382.

    [doi:10.3389/fimmu.2025.1692382]

  • Cano CM, Suárez-Robles M, Ryan P, Hernández-Ruiz V, Guaraldi G, Falutz J, Moreno S, Sánchez-Conde M, Brañas F.

    Advancing integration in the approach to older adults with HIV: perspectives from geriatric and HIV specialists

    BMC GERIATRICS . 25(1): 1040-1040.

    [doi:10.1186/s12877-025-06593-2]

  • Labiod, Nuria, Chamorro-Tojeiro, Sandra, de la Calle-prieto, Fernando, Gutierrez-Lopez, Rafael, Sanchez-Seco, M. Paz, Vazquez, Ana.

    Oropouche Virus, A New Emerging Threat

    CURRENT INFECTIOUS DISEASE REPORTS . 27(1): . Nº de citas: 1

    [doi:10.1007/s11908-025-00862-2]

  • Suarez-Garcia, Ines, Alejos, Belen, Moreno, Cristina, De Miguel, Rosa, Aldamiz-Echevarria, Teresa, Garcia-Fraile, Lucio Jesus, Pitarch, Maria Tasias, Martinez, Desiree Perez, Antela, Antonio, Moreno, Santiago, Jarrin, Inma.

    Effectiveness and tolerability of dolutegravir/lamivudine in virologically suppressed people with HIV at 96 weeks in a multicentre cohort

    HIV MEDICINE . : .

    [doi:10.1111/hiv.70183]

  • de Morales, Alejandro G. Garcia-Ruiz, Vivancos, Maria Jesus, Romero-Hernandez, Beatriz, Rial-Crestelo, David, de las Revillas, Francisco Arnaiz, Sanchez-Villegas, Jorge, Alonso, Marta Montero, Sanchez, Maria De La Villa Lopez, Valls, Maria Remedios Aleman, Moreno, Santiago, Martinez-Sanz, Javier, Perez-Elias, Maria Jesus, CoRIS.

    Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis

    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA . 43(10): 645-651.

    [doi:10.1016/j.eimc.2025.06.016]

  • García-Ruiz de Morales AG, Vivancos MJ, Romero-Hernández B, Rial-Crestelo D, Arnaiz de Las Revillas F, Sanchez-Villegas J, Montero Alonso M, López Sánchez MV, Alemán Valls MR, Moreno S, Martínez-Sanz J, Pérez-Elías MJ.

    Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis.

    Enfermedades Infecciosas Y Microbiologia Clinica (english Ed.) . 43(10): 645-651.

    [doi:10.1016/j.eimce.2025.06.015]

  • Martínez-Sanz J, García-Ruiz de Morales AG, Macías J, Rivero A, Blanco Arévalo JL, Ortiz de Barrón XC, Calzado Isbert S, Novella Mena M, Sánchez-Conde M, Moreno S.

    Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023

    CLINICAL INFECTIOUS DISEASES . : .

    [doi:10.1093/cid/ciaf622]

  • Ryan P, Berenguer J, Ramos-Ruperto L, Vera M, Martín-Carbonero L, Pérez-Latorre L, De Los Santos I, Pinto A, Vivancos MJ, Orviz E, Álvarez B, Sanz J, Ruiz-Seco P, Torres R, Brazal B, De Miguel M, López-Centeno B, Jarrín I, Resino S, Bellón JM, González-García J.

    Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024)

    Open forum infectious diseases . 12(12): .

    [doi:10.1093/ofid/ofaf678]

  • Bravo-Queipo-de-Llano B, Prieto Tato LM, Noguera-Julian A, Escosa-García L, Frick MA, Bustillo M, Ramos JT, Gavilán Martín C, Collado-Hernández P, Navarro Gómez M, Serrano-Villar S, Sainz Costa T.

    Weight Gain Among Children and Adolescents on Dolutegravir in Spain

    Journal of the Pediatric Infectious Diseases Society . 14(12): .

    [doi:10.1093/jpids/piaf110]

  • Casado JL, Blanco JL, Izuzquiza I, Moreno A, Vizcarra P, Vallejo A.

    From TRIO to one: simplification to bictegravir/emtricitabine/tenofovir alafenamide in highly treatment-experienced people living with MDR HIV

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(12): 3242-3247.

    [doi:10.1093/jac/dkaf357]

  • Buzón-Martín L, Montes ML, Pedrero R, Galindo MJ, Santacreu-Guerrero M, Alemán MR, Torralba M, Díaz de Santiago A, Fanjul F, Rodríguez A, Cabello A, Crusells MJ, Navarro MDC, Aguilera M, Hidalgo-Tenorio C, Morano-Amado LE, Vinuesa D, De Andres C, Bernal-Morell E, Martínez-Álvarez RM, Cabello-Clotet N, Tiraboschi J, Montero MDC, Vivancos-Gallego MJ, Díez C, Calderón R, De Zárraga MA, Gisbert L, Romero-Palacios A, Cabo R, Soler JF, Sepúlveda MA, Sánchez-Guirao AJ, Escrich C, Arnaiz De Las Revillas F, Ferreira E, Valentín B, Lérida A, Llenas-García J, Gómez A, Losa JE, Alonso B, Sanz J, Masiá M, Pernas H, Corte JJ, Garcinuño MÁ, Gainzarain JC, Estébanez M, García-Navarro MDM, Barragán P, Ramos N, Clavero M, Millán M, Del Álamo M, Egido M, De La Calle B, Ferrero OL, Troya J.

    A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY . 80(12): 3438-3451.

    [doi:10.1093/jac/dkaf389]

  • Espinosa-Del-Barrio L, Gómez G de la Pedrosa E, Álvarez-Díaz N, Guzmán Martínez J, Corbacho Loarte MD, Escudero Sánchez R, Martín-Dávila P, Fortún Abete J, Cobo Reinoso J, Pintado García V, Gioia F.

    Aspergillus Endocarditis in Native Valves in Non-Traditional Hosts: A Systematic Review of a Case in a Patient with CREST Syndrome and Advanced Liver Cirrhosis.

    JOURNAL OF FUNGI . 11(12): .

    [doi:10.3390/jof11120836]

  • Escudero-Sanchez R, Morata L, Buzón L, de la Villa S, Rico A, Nuñez Orantos MJ, Guio Carrion L, Tasias Pitarch M, Del Pozo JL, Barbero JM, Gómez-Junyent J, García Pais MJ, Bachiller Luque P, Martínez Marcos FJ, Cobo J, Geio Spanish Group For Osteoarticular Infections.

    Dalbavancin as Suppressive Therapy for Implant-Associated Osteoarticular Infections

    ANTIBIOTICS-BASEL . 14(11): .

    [doi:10.3390/antibiotics14111171]